Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels.
about
Epidemiological issues in diabetic retinopathyEfficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial.Current and future pharmacological intervention for diabetic retinopathy.Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy?HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.Multimodality analysis of Hyper-reflective Foci and Hard Exudates in Patients with Diabetic Retinopathy.Modified Lipoproteins in Diabetic Retinopathy: A Local Action in the RetinaEffect of intravitreal bevacizumab on diabetic macular edema with hard exudates.Diabetes-related microvascular and macrovascular diseases in the physical therapy settingSevere combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus.High-Resolution Imaging by Adaptive Optics Scanning Laser Ophthalmoscopy Reveals Two Morphologically Distinct Types of Retinal Hard Exudates.Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy.Fundus autofluorescence and optical coherence tomography findings in branch retinal vein occlusionObesity and eye diseases.Basement membrane changes in capillaries of the ageing human retina.A role for excitatory amino acids in diabetic eye disease.Targeting the retinal microcirculation to treat diabetic sight problems.Should we start all patients with diabetic retinopathy on fenofibrates?Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Long-term diabetic complications may be ameliorated by targeting Rho kinase.A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy.Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF MACULAR EDEMA AND HARD EXUDATES AND THEIR ASSOCIATION WITH LIPID SERUM LEVELS IN TYPE 2 DIABETES.Semi-automated quantification of hard exudates in colour fundus photographs diagnosed with diabetic retinopathy.Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways.Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.Role of lipid-lowering agents in the management of diabetic retinopathy.Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling.HYPERREFLECTIVE DEPOSITION IN THE BACKGROUND OF ADVANCED STARGARDT DISEASE.Role of Inflammation in Diabetic Retinopathy.Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey.Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography.
P2860
Q27003941-A394B227-459B-4DD6-BCDF-E7D2B3339DF0Q31018013-4185901F-F155-4435-95FC-F8B4AD78F31DQ33216425-2A978B1B-3C34-4D87-B160-EDD208FEF060Q33522560-2389DDC5-0BB2-4A99-8D98-BE6B117DEF5AQ33641974-037D5BBE-15F3-4F1F-9A2D-C30A231F43C3Q33685610-9EFE4A5D-20EE-47C1-9587-E27A8353D631Q33942486-52C82528-7686-4F9D-9943-7DAE8482821FQ34062356-5073B9C2-EEA8-46E6-8188-6CE19FE9D3D3Q34830905-52437976-DAD3-444E-AB3D-BBABC1E8DFEDQ35568813-FBBB2B51-21AB-4F6B-B763-1D72823F1025Q36136724-89A2D979-28EE-45DC-92EF-5F5588A838DCQ36179824-A54A4301-3C35-4CE3-AB74-88FE61501ABFQ36415428-2594BBF7-D830-4808-958A-2E4B392399D6Q36758799-AE0CC88C-DF16-4A15-AB20-9977EF6E011FQ36860958-87873C17-1B52-4C5D-8F15-C3C1B81975AFQ36916674-A3C118F6-8A31-4E84-9FD3-2796A54F1F0AQ37008851-4FFD7226-86FA-45BF-9F0B-8B516460F967Q37346390-A4CFA6C8-19F5-4A68-A982-6825FAFF1C7AQ37477129-D83A3EA2-1348-4D3B-A048-504BEACE8A7FQ37838899-8B362957-4EBF-4F41-89BE-14A5D3CAC3F6Q38944230-3BF3A6CA-AE19-45D9-9A1B-997AB6B83A95Q40076168-D104AB1C-8018-4687-B4CF-B7FC3227C103Q40845586-8CD67435-94E1-416E-9DAC-088F2215A924Q41695768-E04E1EDF-7056-40A3-8572-5005FD0D06EEQ41810320-82616C49-B0B7-4FA4-965E-414D6DAF8423Q42215654-A736F240-6796-4D51-BF0C-59683659D913Q42235245-7846CCE0-4099-4D11-BAD4-BDBB8A75A517Q42330281-869BD659-3F17-4A24-B66A-4BB9AC18F1A3Q45980806-298F8EEC-3D23-4A2E-94D7-31C5561B24ACQ47802263-BE0C66E7-35A7-4AB7-9440-C1D4F25BE436Q52642996-73787EA5-7D25-42E5-B719-92C3F2A97113Q53552556-3BB3ED49-3153-4D41-89EF-B11181165DC2Q54975631-387D39FE-94CD-4075-A7F5-C1CDCEBA27D5Q55259517-90B5BB49-AE14-48D4-A02B-3BB363B33A6F
P2860
Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Histopathology and regression ...... f elevated serum lipid levels.
@ast
Histopathology and regression ...... f elevated serum lipid levels.
@en
type
label
Histopathology and regression ...... f elevated serum lipid levels.
@ast
Histopathology and regression ...... f elevated serum lipid levels.
@en
prefLabel
Histopathology and regression ...... f elevated serum lipid levels.
@ast
Histopathology and regression ...... f elevated serum lipid levels.
@en
P2093
P1433
P1476
Histopathology and regression ...... f elevated serum lipid levels.
@en
P2093
Frederick L Ferris
Howard S Kruth
Michael Cusick
Robert P Murphy
P304
P356
10.1016/J.OPHTHA.2003.01.001
P577
2003-11-01T00:00:00Z